{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:32Z","timestamp":1793500532692,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The clinical presentation of adult-onset immunodeficiency with anti-interferon (IFN)-\u03b3 autoantibodies with intracellular pathogens can be highly variable, which can lead to misdiagnosis during the early stage of disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a complex case of a 54-year-old Chinese male who was human immunodeficiency virus-negative. He had a presence of anti-IFN-\u03b3 autoantibodies and suffered from various intracellular pathogenic infections. The patient was admitted to our hospital for the first time in July 2016 with severe pneumonia, and he experienced multiple pneumonia infections between 2017 and 2019. In March 2019, the patient was hospitalized due to pulmonary lesions and multiple-bone destruction. During hospitalization, the patient was confirmed to have disseminated <jats:italic>Talaromyces marneffei<\/jats:italic> infection and was successfully treated with antifungal therapy for 1\u00a0year. In June 2021, <jats:italic>Mycobacterium kansasii<\/jats:italic> infection was detected by positive culture and progressive bone destruction. A high concentration of anti-IFN-\u03b3 antibodies was observed in the patient\u2019s serum. In addition, <jats:italic>Listeria monocytogenes<\/jats:italic> was isolated by blood culture, and the presence of <jats:italic>L. monocytogenes<\/jats:italic> in cerebrospinal fluid was confirmed by next-generation sequencing. Following anti-non-tuberculous mycobacteria (NTM) therapy and anti-bacterial therapy, the patient\u2019s symptoms, pulmonary lesions, and bone destruction gradually improved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although the clinical presentation of adult-onset immunodeficiency with anti-IFN-\u03b3 autoantibodies can be highly variable, the diagnosis should be considered if patients suffer from unexplained repeated bacterial or opportunistic infections.<\/jats:p>\n                <jats:p>Conventional and advanced molecular testing should be used, as needed, for microbiological diagnoses among this special immunodeficient population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08404-8","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T13:03:04Z","timestamp":1690376584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Multiple refractory intracellular pathogen infections in a human immunodeficiency virus-negative patient with anti-interferon-\u03b3 autoantibodies: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Hongxia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"1","key":"8404_CR1","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1086\/380453","volume":"38","author":"R D\u00f6ffinger","year":"2004","unstructured":"D\u00f6ffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, Espitia-Pinzon C, Barnes N, Bothamley G, Casanova JL, Longhurst HJ, Kumararatne DS. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38(1):e10\u20134.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"8404_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh PR, Shieh CC, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, Rosen LB, Mo A, Iadarola M, Holland SM. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725\u201334.","journal-title":"N Engl J Med"},{"issue":"6","key":"8404_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/cid\/civ995","volume":"62","author":"YL Xie","year":"2016","unstructured":"Xie YL, Rosen LB, Sereti I, Barber DL, Chen RY, Hsu DC, Qasba SS, Zerbe CS, Holland SM, Browne SK. Severe paradoxical reaction during treatment of disseminated tuberculosis in a patient with neutralizing anti-IFN\u03b3 autoantibodies. Clin Infect Dis. 2016;62(6):770\u20133.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8404_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/1535370218764086","volume":"243","author":"J Wipasa","year":"2018","unstructured":"Wipasa J, Chaiwarith R, Chawansuntati K, Praparattanapan J, Rattanathammethee K, Supparatpinyo K. Characterization of anti-interferon-\u03b3 antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms. Exp Biol Med (Maywood). 2018;243(7):621\u20136.","journal-title":"Exp Biol Med (Maywood)"},{"key":"8404_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijid.2020.02.037","volume":"93","author":"X Liang","year":"2020","unstructured":"Liang X, Si L, Li Y, Zhang J, Deng J, Bai J, Li M, He Z. Talaromyces marneffei infection relapse presenting as osteolytic destruction followed by suspected nontuberculous mycobacterium infection during 6 years of follow-up: a case update. Int J Infect Dis. 2020;93:208\u201310.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"8404_CR6","doi-asserted-by":"publisher","first-page":"ofw093","DOI":"10.1093\/ofid\/ofw093","volume":"3","author":"N Pruetpongpun","year":"2016","unstructured":"Pruetpongpun N, Khawcharoenporn T, Damronglerd P, Suthiwartnarueput W, Apisarnthanarak A, Rujanavej S, Suwantarat N. Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-\u03b3 autoantibodies. Open Forum Infect Dis. 2016;3(2):ofw093.","journal-title":"Open Forum Infect Dis"},{"key":"8404_CR7","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2147\/IDR.S218836","volume":"12","author":"SS Su","year":"2019","unstructured":"Su SS, Zhang SN, Ye JR, Xu LN, Lin PC, Xu HY, Wu Q, Li YP. Disseminated Talaromyces marneffei and Mycobacterium avium infection accompanied Sweet\u2019s syndrome in a patient with anti-interferon-\u03b3 autoantibodies: A case report. Infect Drug Resist. 2019;12:3189\u201395.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"8404_CR8","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1186\/s12879-020-05553-y","volume":"20","author":"M Roerden","year":"2020","unstructured":"Roerden M, D\u00f6ffinger R, Barcenas-Morales G, Forchhammer S, D\u00f6bele S, Berg CP. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies. BMC Infect Dis. 2020;20(1):828.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8404_CR9","doi-asserted-by":"publisher","first-page":"300060520976471","DOI":"10.1177\/0300060520976471","volume":"49","author":"W Jin","year":"2021","unstructured":"Jin W, Liu J, Chen K, Shen L, Zhou Y, Wang L. Coinfection by Talaromyces marneffei and Mycobacterium abscessus in a human immunodeficiency virus-negative patient with anti-interferon-\u03b3 autoantibody: a case report. J Int Med Res. 2021;49(1):300060520976471.","journal-title":"J Int Med Res"},{"issue":"1","key":"8404_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12879-021-07015-5","volume":"22","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Pan M, Yang Z, Zeng W, Zhang H, Li Z, Zhang J. Talaromyces marneffei and Mycobacterium tuberculosis co-infection in a patient with high titer anti-interferon-\u03b3 autoantibodies: a case report. BMC Infect Dis. 2022;22(1):98.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"8404_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1128\/CVI.00053-10","volume":"17","author":"BS Tang","year":"2010","unstructured":"Tang BS, Chan JF, Chen M, Tsang OT, Mok MY, Lai RW, Lee R, Que TL, Tse H, Li IW, To KK, Cheng VC, Chan EY, Zheng B, Yuen KY. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol. 2010;17(7):1132\u20138.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"8404_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000347112","volume":"226","author":"JF Chan","year":"2013","unstructured":"Chan JF, Trendell-Smith NJ, Chan JC, Hung IF, Tang BS, Cheng VC, Yeung CK, Yuen KY. Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: sweet\u2019s syndrome and beyond. Dermatology. 2013;226(2):157\u201366.","journal-title":"Dermatology"},{"issue":"1","key":"8404_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s15010-010-0067-3","volume":"39","author":"T Kampitak","year":"2011","unstructured":"Kampitak T, Suwanpimolkul G, Browne S, Suankratay C. Anti-interferon-\u03b3 autoantibody and opportunistic infections: case series and review of the literature. Infection. 2011;39(1):65\u201371.","journal-title":"Infection"},{"issue":"1","key":"8404_CR14","doi-asserted-by":"publisher","first-page":"16177","DOI":"10.1038\/s41598-021-95686-0","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Huang J, Li Y, Zeng W, Pan M, Cen J, Zhang H, Sun X, Qu D, Zhang J. Talaromyces marneffei and nontuberculous mycobacteria co-infection in HIV-negative patients. Sci Rep. 2021;11(1):16177.","journal-title":"Sci Rep"},{"issue":"3","key":"8404_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s10875-022-01210-y","volume":"42","author":"YC Chen","year":"2022","unstructured":"Chen YC, Weng SW, Ding JY, Lee CH, Ku CL, Huang WC, You HL, Huang WT. Clinicopathological manifestations and immune phenotypes in adult-onset immunodeficiency with anti-interferon-\u03b3 autoantibodies. J Clin Immunol. 2022;42(3):672\u201383.","journal-title":"J Clin Immunol"},{"key":"8404_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","volume":"72","author":"HP Shih","year":"2021","unstructured":"Shih HP, Ding JY, Yeh CF, Chi CY, Ku CL. Anti-interferon-\u03b3 autoantibody-associated immunodeficiency. Curr Opin Immunol. 2021;72:206\u201314.","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"8404_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","volume":"121","author":"CY Chi","year":"2013","unstructured":"Chi CY, Chu CC, Liu JP, Lin CH, Ho MW, Lo WJ, Lin PC, Chen HJ, Chou CH, Feng JY, Fung CP, Sher YP, Li CY, Wang JH, Ku CL. Anti-IFN-\u03b3 autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357\u201366.","journal-title":"Blood"},{"issue":"3","key":"8404_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","volume":"137","author":"CL Ku","year":"2016","unstructured":"Ku CL, Lin CH, Chang SW, Chu CC, Chan JF, Kong XF, Lee CH, Rosen EA, Ding JY, Lee WI, Bustamante J, Witte T, Shih HP, Kuo CY, Chetchotisakd P, Kiertiburanakul S, Suputtamongkol Y, Yuen KY, Casanova JL, Holland SM, Doffinger R, Browne SK, Chi CY. Anti-IFN-\u03b3 autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(3):945-8.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"8404_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.841674","volume":"9","author":"D Li","year":"2022","unstructured":"Li D, Liang H, Zhu Y, Chang Q, Pan P, Zhang Y. Clinical characteristics, laboratory findings, and prognosis in patients with Talaromyces marneffei infection across various immune statuses. Front Med (Lausanne). 2022;9: 841674.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"8404_CR20","first-page":"210","volume":"25","author":"P Pagliano","year":"2017","unstructured":"Pagliano P, Arslan F, Ascione T. Epidemiology and treatment of the commonest form of listeriosis: meningitis and bacteraemia. Infez Med. 2017;25(3):210\u20136.","journal-title":"Infez Med"},{"key":"8404_CR21","doi-asserted-by":"crossref","unstructured":"Schlech WF. Epidemiology and clinical manifestations of Listeria monocytogenes infection. Microbiol Spectr. 2019;7(3).","DOI":"10.1128\/microbiolspec.GPP3-0014-2018"},{"issue":"17","key":"8404_CR22","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","volume":"119","author":"SK Browne","year":"2012","unstructured":"Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, Pancholi MJ, Yang LM, Priel DL, Uzel G, Freeman AF, Hayes CE, Baxter R, Cohen SH, Holland SM. Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119(17):3933\u20139.","journal-title":"Blood"},{"issue":"6","key":"8404_CR23","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/cid\/cit809","volume":"58","author":"CA Czaja","year":"2014","unstructured":"Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-\u03b3 autoantibody. Clin Infect Dis. 2014;58(6):e115\u20138.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"8404_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s10875-017-0425-3","volume":"37","author":"Y Koizumi","year":"2017","unstructured":"Koizumi Y, Sakagami T, Nishiyama N, Hirai J, Hayashi Y, Asai N, Yamagishi Y, Kato H, Hagihara M, Sakanashi D, Suematsu H, Ogawa K, Mikamo H. Rituximab restores IFN-\u03b3-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with anti-interferon-\u03b3 autoantibody. J Clin Immunol. 2017;37(7):644\u20139.","journal-title":"J Clin Immunol"},{"key":"8404_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2022.105333","volume":"13","author":"X Sun","year":"2022","unstructured":"Sun X, Shen B, Yu H, Wu W, Sheng R, Fang Y, Guo R. Therapeutic potential of demethylzeylasteral, a triterpenoid of the genus Tripterygium wilfordii. Fitoterapia. 2022;13: 105333.","journal-title":"Fitoterapia"},{"key":"8404_CR26","doi-asserted-by":"publisher","first-page":"5314105","DOI":"10.1155\/2022\/5314105","volume":"2022","author":"M Chen","year":"2022","unstructured":"Chen M, Zhang P, Li L, Yu Z, Liu N, Wang L. Efficacy and safety of glycosides of Tripterygium wilfordii combined with renin-angiotensin system in the treatment of IgA nephropathy: A systematic review and meta-analysis. Emerg Med Int. 2022;2022:5314105.","journal-title":"Emerg Med Int"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08404-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T13:03:15Z","timestamp":1690376595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08404-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8404"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08404-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee at the University of Hong Kong\u2014Shenzhen Hospital and complied with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of the case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflicts of interest, financial or otherwise are declared by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"493"}}